Rising Products
Late stage pipeline
2021 Launch
Near term launch
Current Portfolio
112 product families and 19 pipeline products expected to launch in the next 12 months.
441 SKUs generating 4.5 billion doses per year.
Large and broad position in solid oral dosage products as well as a strong position in topicals and oral liquids.
Read more about Rising’s response to the COVID-19 pandemic here.
Read more about Rising’s response to the COVID-19 pandemic here.
From our manufacturers, partners and pharmacies to physicians and their patients, our goal is to make life better for everyone we impact.